Hexicon AB

As of June 30, 2026, Hexicon AB carries a market capitalization of 3.64M, placing it among publicly traded companies globally. Its enterprise value stands at 88.28M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Hexicon AB's next confirmed earnings release is scheduled for November 26, 2026.

As of June 30, 2026, Hexicon AB has 363.80M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 3.87, and the price-to-book ratio stands at -0.06.

These figures are as of June 30, 2026. The EV/Sales ratio of 94.02 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 88.28M versus a market cap of 3.64M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Hexicon AB maintains a current ratio of 1.86, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -150.64, indicating conservative leverage, while an interest coverage ratio of -0.29 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -72.99, reflecting losses generated across the asset base. The company generates approximately 44,711.35 in revenue per employee across its workforce of 21.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Hexicon AB recorded 54,169.52 in income tax expense. The company reported a pretax loss of -32.57M and -32.64M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Hexicon AB's stock has declined approximately 41.86% over the past 52 weeks. The 50-day moving average sits at 0.01, while the 200-day moving average is 0.01.

Over the twelve months ended June 30, 2026, Hexicon AB generated 938,938.35 in revenue and converted that into -32.64M in net income, yielding earnings per share of -0.09. EBITDA reached -5.36M, while operating income came in at -16.60M.

As of June 30, 2026, Hexicon AB holds 297,932.36 in cash and equivalents against 85.00M in total debt, resulting in a net debt position of 84.70M. Total book value stands at -56.36M, with working capital of 11.94M providing operational flexibility.

Hexicon AB produced -4.92M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -577,808.22 in capital expenditures, free cash flow totaled -5.50M - equivalent to -0.02 per share.

These figures cover the twelve months ended June 30, 2026. The operating margin of -1,768.27 and net profit margin of -3,475.96 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -151.13: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -131.03, meaning Hexicon AB raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Hexicon AB has an Altman Z-Score of -5.34, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.